FDA Clearance Tracker · DEN160006
everlinQ endoAVF System
Last checked: Nov 20, 2026Latest source record: Jun 22, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2018
De Novo granted
Time to decision
870 days
Received Feb 3, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN160006
- Device name
- everlinQ endoAVF System
- Applicant
- Tva Medical, Inc.
- Applicant location
- Austin, TX
- Received
- Feb 3, 2016
- Decided
- Jun 22, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Percutaneous Catheter For Creation Of An Arteriovenous Fistula For Hemodialysis Access (PQK)
- Device class
- Class II
- Regulation
- 21 CFR 870.1252
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not the first decision under product code PQK. The earliest in FDA's data is DEN170004, decided Jun 22, 2018.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN160006
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Tva Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K162656 · Decided Nov 10, 2016 · 48 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.